Archer Capital

A shift in Australian private equity has left firms like Archer, which has decided not to continue raising its sixth fund, without deep institutional backing.

The Australian firm has sold Healthe Care to China’s Luye Medical Group for $700 million and reportedly acquired a stake in New Zealand Pharmaceuticals.

The Australian buyout firm has acquired five New Zealand privately education business through Archer Capital Fund V. The fund is an AUD 1.5 billion, 2011 vehicle that returned AUD 300 million to investors in November 2014.

The Australian country manager has secured a Switzerland-based buyer for its independent oil company investment Ausfuel.

The Australian country manager has secured a Switzerland-based buyer for its independent oil company investment Ausfuel.

Tax documentation covering Archer Capital's 2011 secondary sale of MYOB has been requested in an ongoing legal dispute between Archer and Sage Group.

Archer’s ‘strongly oversubscribed’ fifth fund has beat it’s $1.27bn target after only four months on the market.

The firm has agreed to sell its stake in Onesource Group and Leasing Solutions to Australian technology company GSG in a deal that values the businesses at NZ$132m.

A look inside Private Equity International's upgraded and new-look fundraising database. Plus: GPs are pre-empting issues relating to sanctioned investors within fund docs and Australia's Potentia has closed its sophomore fund. Here's today's brief, for our valued subscribers only.

The firm has also 'materially concluded' fundraising for its latest flagship, chief executive Christian Sinding said on its earnings call on Wednesday.

Another of Australia's PE brands faces an uncertain future. Plus: LPs are feeling sanguine about GP transparency. Here's today's brief, for our valued subscribers only.

CHAMP’s decision to rebrand as CPE Capital caps a decade-long transition of leadership from its founders to chief executive John Haddock.

As some of the country’s old guard struggle to navigate leadership transitions, a new wave of managers has emerged.

CHAMP V Fund would be more than 20% larger than its 2016-vintage predecessor, Private Equity International has learned.

The deal-by-deal firm is expected to target as much as A$300m when it comes to market in 2020.

Potentia Capital is expecting to hold an H1 close on Australia’s first dedicated mid-market technology vehicle.